-
Letter soliciting opinions on the terminology of functional categories of pharmaceutical excipients under the Chinese Pharmacopoeia
Time of Update: 2023-01-05
Letter soliciting opinions on the terminology of functional categories of pharmaceutical excipients under the Chinese Pharmacopoeia Source: National Pharmacopoeia Commission Time: 2022-11-22 20:11:07
-
The press conference of the joint prevention and control mechanism of the State Council responded to the focus issue
Time of Update: 2023-01-05
Recently, the comprehensive group of the joint prevention and control mechanism of the State Council has deployed and dispatched all localities to promote the implementation of 20 optimization measures as soon as possible through various methods such as video consultation, scheduling and training.
-
20 antihypertensive drugs are selling well, and 4 major product brands have broken through!
Time of Update: 2023-01-05
3 major varieties of more than 1 billion are entrenched in the 10 billion market, and 4 domestic brands are listed in the TOP20 Sales of hypertensive drugs in China's urban physical pharmacies in recent years (: 100 million yuan)Source: Competition pattern of drug terminals in China's urban physical pharmacies According to data from Minai.
-
During the year, thousands of executives in the A-share biomedical industry have left
Time of Update: 2023-01-05
js?cdnversion='+~(-new Date()/36e5)];In the pharmaceutical industry, the departure of senior executives of pharmaceutical companies has long become the norm, and since November this year, there have been many more cases, mostly due to personal reasons.
-
More than 350 pharmaceutical companies have changed their senior management, focusing on chemical drugs, traditional Chinese medicine, APIs and other fields
Time of Update: 2023-01-05
From the perspective of the subdivision track to which these enterprises belong, they are mainly concentrated in the fields of chemical drugs, traditional Chinese medicine, and APIs. In the field of chemical medicine, such as the "first brother of medicine" Hengrui, senior management changes frequently during the year, among which deputy general managers Zhang Yuehong, Zou Jianjun, Tao Weikang, etc.
-
What's next for the pharmaceutical sector? Innovative pharmaceutical companies are optimistic about the industry
Time of Update: 2023-01-05
js?cdnversion='+~(-new Date()/36e5)];Recently, the pharmaceutical sector has risen strongly.
js?cdnversion='+~(-new Date()/36e5)];Recently, the pharmaceutical sector has risen strongly.
js?cdnversion='+~(-new Date()/36e5)];Recently, the pharmaceutical sector has risen strongly.
js?cdnversion='+~(-new Date()/36e5)];Recently, the pharmaceutical sector has risen strongly.
-
During the year, the amount of additional funds raised by the three pharmaceutical companies exceeded 3.5 billion yuan, of which one exceeded 10 billion yuan
Time of Update: 2023-01-05
Aier Ophthalmology: A total of approximately RMB3,536 million was raised during the year Aier Eye released the results of the fixed increase on November 11, showing that the number of shares issued was about 133 million shares at a price of 26.
-
The development of the biopharmaceutical industry is favored by policies, which stimulates the acceleration of local innovation of biopharmaceutical consumables and equipment
Time of Update: 2023-01-05
The development of the biomedical industry is accelerating, stimulating local innovation in pharmaceutical equipment (Image source: Pharmaceutical Network) For example, recently, the Shanghai Municipal Science and Technology Commission, the Municipal Economic Information Commission, and the Municipal Health Commission jointly issued the "Shanghai Action Plan for Promoting Cell Therapy Science and Technology Innovation and Industrial Development (2022-2024)".
-
Pharmaceutical biology "absorbs gold" fiercely, with a net purchase of nearly 10.4 billion yuan in financing in November
Time of Update: 2023-01-05
According to statistics, since November, the net purchase of A-share financing has reached more than 28 billion yuan.
According to statistics, since November, the net purchase of A-share financing has reached more than 28 billion yuan.
-
2023 Shanghai Medical Exhibition
Time of Update: 2023-01-05
2023 Shanghai International Medical Equipment Exhibition China International Medical Equipment Fair 2023 The Shang Hai interna tional Medical Devices Exhibition Date: June 28-30, 2023 Venue: Shanghai
-
32 pharmaceutical companies were investigated by institutions, and the stock price of one stock rose 101% in a month
Time of Update: 2023-01-05
According to the data, Teyi Pharmaceutical is mainly engaged in the research and development, production and sales of proprietary Chinese medicines, chemical preparations and chemical APIs. The analysis believes that the recent active performance of the stock is mainly related to its products in cough and fever reducers.
-
Announcement on the adjustment of the schedule of the 88th API China and the 26th CHINA-PHARM
Time of Update: 2023-01-05
Dear exhibitors, visitors and industry friends, In view of the recent situation of the national epidemic facing many points, wide areas and frequent occurrences, and the severe and complex prevention
-
The intensive development of pharmacies has accelerated, and single stores will be eliminated
Time of Update: 2023-01-05
Last year, the Ministry of Commerce issued the "Guiding Opinions on Promoting the High-quality Development of the Pharmaceutical Circulation Industry during the 14th Five-Year Plan" Period (hereinaft
-
High performance - analysis of the situation of some medical device listed companies in the first three quarters
Time of Update: 2023-01-05
According to the statistics of Medical Equipment Data Cloud, as of October 31, a total of 120 listed medical device companies have issued performance reports, and more than 90% of the company's revenue and net profit in the first three quarters have maintained a growth trend.
-
Recently, a number of domestic new drugs have ushered in clinical trials and good news for marketing
Time of Update: 2023-01-05
In the increasingly crowded R&D track and fiercer market competition, many pharmaceutical companies are accelerating the promotion of scientific and technological innovation and internationalization
-
2023 Shanghai International Medical Equipment Exhibition
Time of Update: 2023-01-05
2023 Shanghai International Medical Equipment ExhibitionChina International Medical Equipment Fair 2023 The Shang Hai interna tional Medical Devices Exhibition Date: June 28-30, 2023 Venue: Shanghai
-
How do the new regulations on change management during the review of drug registration applications consider to avoid preemptive positions?
Time of Update: 2023-01-05
1 If the matters or contents specified in the original drug registration approval document and its annexes are changed, the applicant shall, in accordance with the provisions and with reference to the relevant technical guidelines, conduct full research and verification of the drug change, fully assess the impact that the change may have on the safety, efficacy and quality controllability of the drug, and submit a supplementary application, filing or report in accordance with the change procedure (Article 11).
-
23 pharmaceutical companies surveyed by institutions! Some pharmaceutical companies have received more than 300 institutional attention
Time of Update: 2023-01-05
(Image source: Pharma Network) Judging from the pharmaceutical stocks investigated by institutions in the past 5 days, Gibel has attracted the attention of institutions, with the number of institutional researchers as high as 301, including China Re Asset, CSC, CICC, China Europe Fund, etc.
-
PD-1, CAR-T, rare disease medication... On the eve of the national talks, can the new batch of VAT exemptions accelerate the price reduction of high-priced drugs?
Time of Update: 2023-01-05
The "tax reduction list" of anticancer drugs and rare disease drugs was further expanded In April 2018, the Ministry of Finance and other four departments issued a notice on their official website that in order to encourage the development of the anti-cancer pharmaceutical industry and reduce the cost of drugs for patients, the first batch of anti-cancer drugs in the list will be subject to 3% VAT, and the VAT will be reduced from 13% to 3% for imported drugs.
-
The digital and intelligent transformation of the pharmaceutical industry is timely, and pharmaceutical equipment companies are here to help
Time of Update: 2023-01-05
The digital transformation of the pharmaceutical industry is timely In recent years, with the rapid development of new technologies such as digitalization, artificial intelligence, and 5G, it has brought great changes to the traditional manufacturing industry.
